Regent Peak Wealth Advisors LLC Edwards Lifesciences Corp Transaction History

Regent Peak Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$101.96 - $128.34 $170,273 - $214,327	-1,670 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $177,637 - $218,235	1,670 New	1,670 $216,000
Q1 2021 Apr 28, 2021	SELL	$78.68 - $90.67 $128,641 - $148,245	-1,635 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $117,213 - $149,161	1,635 New	1,635 $149,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.